Document is current
Any future updates will be listed below
-
Authors
Guillou Landreat, Morgane https://orcid.org/0000-0003-1568-9480
Dany, Antoine
Challet Bouju, Gaelle
Laforgue, Edouard-Jules
Cholet, J.
Leboucher, Juliette
Hardouin, Jean Benoit
,
Bodenez, Pierre
Grall-Bronnec, Marie
Guillou-Landreat, Morgane
Le Geay, Bertrand
Martineau, Isabelle
Levassor, Philippe
Bolo, Paul
Guillet, Jean-Yves
Guillery, Xavier
Dano, Corine
Victorri Vigneau, Caroline
Grall Bronnec, Marie
-
Funding
Funding for this research was provided by:
Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives (PREVDROG 2011)
Université Paris-Est Créteil Val-de-Marne (PREVDROG 2011)
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 4 March 2022
First Online: 28 March 2022
Declarations
:
: The studies involving human participants were reviewed and approved by Groupe Nantais d’Éthique dans le Domaine de la Santé (GNEDS), the Advisory Committee on the Processing of Health Research Information (CCTIRS) and the Data Protection Commission (CNIL). The patients/participants provided written informed consent to participate in this study. The OPAL study was registered: (NCT01847729).
: All authors have read and approved the manuscript.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
